Literature DB >> 15629730

Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics.

Daniel H Solomon1, M Alan Brookhart, Tejal K Gandhi, Andrew Karson, Soheyla Gharib, E John Orav, Shimon Shaykevich, Andrea Licari, Danielle Cabral, David W Bates.   

Abstract

PURPOSE: The diagnosis and treatment of patients at risk of fragility fractures is uncommon. We examined the patient, physician, and practice characteristics associated with adherence to local osteoporosis guidelines.
METHODS: Data were obtained from electronic medical records from one academic medical center. Local guidelines suggest screening and consideration of treatment for at-risk patients, including women aged > or =65 years, women aged 50 to 64 years who smoke cigarettes, persons who used more than 5 mg of oral prednisone for >3 months, and those with a history of a fracture after age 45 years. Clinical notes, medication lists, and radiology records were reviewed to determine whether patients had undergone bone mineral density testing or received any medications for osteoporosis. Possible correlates of guideline adherence, including patient, physician, and practice site characteristics, were assessed in mixed multivariable models.
RESULTS: We identified 6311 at-risk patients seen by 160 doctors at 10 primary care sites during 2001 to 2002. Of these patients, 45% (n = 2820) had a prior bone mineral density test and 30% (n = 1922) had received a medication for osteoporosis; 54% (n = 3401) had one or the other. After adjusting for patient case mix, 17% to 71% of patients had been managed according to local guidelines and had undergone at least bone mineral density testing or received a medication. Patient variables that significantly lowered the probability of guideline adherence included age >74 years (odds ratio [OR] = 0.49; 95% confidence interval [CI]: 0.43 to 0.55), age <55 years (OR = 0.34; 95% CI: 0.28 to 0.42), male sex (OR = 0.17; 95% CI: 0.12 to 0.23), black race (OR = 0.40; 95% CI: 0.34 to 0.47), and having more than one comorbid condition (OR = 0.79; 95% CI: 0.69 to 0.89). Patients seen by male physicians were less likely to have care that was adherent with guidelines (OR = 0.70; 95% CI: 0.55 to 0.89).
CONCLUSION: Rates of adherence with local osteoporosis guidelines for patients at risk of fragility fractures vary by patient, physician, and practice site characteristic.

Entities:  

Mesh:

Year:  2004        PMID: 15629730     DOI: 10.1016/j.amjmed.2004.06.040

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  39 in total

1.  Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.

Authors:  E V McCloskey; H Johansson; N C Harvey; J Compston; J A Kanis
Journal:  Osteoporos Int       Date:  2016-07-20       Impact factor: 4.507

2.  An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines.

Authors:  R Baddoura; H Awada; J Okais; M Salamoun; G Ayoub; N Ziadé; G El Hajj-Fuleihan
Journal:  Osteoporos Int       Date:  2006-05-03       Impact factor: 4.507

3.  David Westfall Bates, MD: a conversation with the editor on improving patient safety, quality of care, and outcomes by using information technology. Interview by William Clifford Roberts.

Authors:  David Westfall Bates
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-04

Review 4.  [Glucocorticoid induced osteoporosis].

Authors:  U Lange; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2007-03       Impact factor: 1.372

5.  Correlates of use of antifracture therapy in older women with low bone mineral density.

Authors:  Kathryn M Ryder; Ronald I Shorr; Frances A Tylavsky; Andrew J Bush; Douglas C Bauer; Eleanor M Simonsick; Elsa S Strotmeyer; Tamara B Harris
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

6.  Factors affecting willingness to get assessed and treated for osteoporosis.

Authors:  Y H Roh; E S Lee; J Ahn; H S Kim; H S Gong; K H Baek; H Y Chung
Journal:  Osteoporos Int       Date:  2019-04-03       Impact factor: 4.507

Review 7.  Quality health care gaps in osteoporosis: how can patients, providers, and the health system do a better job?

Authors:  Gim Gee Teng; Jeffrey R Curtis; Kenneth G Saag
Journal:  Curr Osteoporos Rep       Date:  2009-03       Impact factor: 5.096

8.  Factors associated with osteoporosis screening and recommendations for osteoporosis screening in older adults.

Authors:  Smita Nayak; Mark S Roberts; Susan L Greenspan
Journal:  J Gen Intern Med       Date:  2009-03-10       Impact factor: 5.128

9.  Factors associated with diagnosis and treatment of osteoporosis in older adults.

Authors:  S Nayak; M S Roberts; S L Greenspan
Journal:  Osteoporos Int       Date:  2009-01-17       Impact factor: 4.507

10.  Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA.

Authors:  C Asche; R Nelson; C McAdam-Marx; M Jhaveri; X Ye
Journal:  Osteoporos Int       Date:  2009-10-02       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.